Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. | Zendy

Matthias Pfisterer | Zendy; Wolfgang Kiowski | Zendy; H Brunner | Zendy; D Burckhardt | Zendy; F Burkart | Zendy

Open Access

Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction.

Author(s) -

Matthias Pfisterer,

Wolfgang Kiowski,

H Brunner,

D Burckhardt,

F Burkart

Publication year - 1993

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.87.2.309

Subject(s) - amiodarone , medicine , discontinuation , myocardial infarction , cardiology , asymptomatic , anesthesia , atrial fibrillation

In the Basel Antiarrhythmic Study of Infarct Survival trial, low-dose amiodarone improved 1-year survival in patients with asymptomatic complex ventricular arrhythmias persisting 2 weeks after myocardial infarction. To assess whether this beneficial effect persisted despite discontinuation of amiodarone after 1 year, the long-term outcomes of all patients of the amiodarone-treated group (initially n = 98) and those of the control group (n = 114) were assessed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research